KOSDAQChemicals0007C0

Acryl

₩18,530▼ 1.38%2026-10-02 close

Market Cap

₩148.4B

Turnover

₩1.2B

Volume

60,000 shares

Shares out.

PER

—

PBR

—

EPS

—

Dividend Yield

—

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-10-02 close

Report overview

Order Surge Tests the Breakeven Promise

With Q1 2026 orders up 86% YoY to KRW 20.7bn and revenue surging 123%, the path to Acryl's first-ever operating profit is becoming tangible—but legacy losses and shareholder overhang remain key watchpoints.

1
Q1 2026 revenue of KRW 6.57bn (+123% YoY) and order intake of KRW 20.7bn (+86% YoY) improve visibility on full-year targets of KRW 27.7bn revenue and KRW 3.3bn operating income
2
12 government AI project wins in 2025 and potential orders from NVIDIA's 260,000-GPU domestic deployment program (targeted for Q3 2026) represent key medium-term growth drivers
3
FY2025 results (revenue KRW 13.3bn, operating loss KRW 2.3bn, net loss KRW 2.8bn) showed revenue slightly below the IPO forecast but meaningfully narrower losses than projected, confirming the profitability improvement trajectory
4
Overhang risk persists as lock-up expirations approach for multiple financial investors including LG Electronics (7.96%, second-largest shareholder), creating sustained downside supply pressure
5
Meeting the 2027 net income target of approximately KRW 10.3bn requires successful revenue expansion into mid-sized corporates, pharma and healthcare, with 2026 breakeven as the prerequisite milestone

Business structure

Acryl was founded in 2011 by CEO Park Wae-jin, a KAIST computer science PhD, and is positioned as a full-stack AI transformation (AX) infrastructure company supporting AI service deployment and operations end-to-end; the company went public on KOSDAQ via a technology special listing in December 2025.

Its two flagship product lines are the integrated AI platform 'Jonathan' and the healthcare-focused AI platform 'NADIA.' Jonathan is an end-to-end platform covering data preprocessing and labeling, model training and deployment, MLOps/LLMOps, validation, and retraining, reportedly reducing AI development costs and timelines by over 70% through GPU resource optimization.

Revenue mix in 2024 comprised Jonathan at 46.8%, government information subsidies at 27.1%, consulting services at 18.0%, and NADIA at 8.1%, meaning platform revenue and public subsidies account for roughly three-quarters of total sales.

NADIA is a healthcare AI platform for medical data integration and AI-assisted diagnosis, with overseas installations at public hospitals in Uzbekistan and an AI-native EMR product (NADIA-ANE) in active development.

The company's GPUBASE GPU cluster optimization software is being nurtured as a new growth engine, and its proprietary LLM 'Areum (A-LLM)' ranked first in the domestic open-source LLM leaderboard in August 2024.

Key customers include Samsung E&A, Samsung Welstory, and Seegene, totaling approximately 80 clients, while strategic investors LG Electronics and SK C&C provide access to major conglomerate ecosystems.

Domestic competitors include Upstage, Nota, KeyTalk AI, and Aillus, but Acryl's combination of GPU infrastructure optimization, public sector track record, and specialized healthcare platform constitutes a meaningful differentiation.

With approximately 90 employees and over 50 patents, the company has earned recognition including Forbes Korea 'AI 50' for two consecutive years.

Recent trends

Acryl debuted on KOSDAQ in December 2025 via the technology innovation company listing track, attracting institutional bid-to-cover of 791x and retail subscription of 1,130x, raising total IPO proceeds of KRW 42.1bn.

The IPO price was set at the top of the range at KRW 19,500, and the stock surged to an intraday high of KRW 77,000 on its first day, opening 135% above the IPO price.

However, the stock has retreated materially since listing, trading at KRW 27,500 as of June 5, 2026 (+1.85% vs. prior close), a 64% pullback from the listing-day peak, with a 52-week range of KRW 24,750 to KRW 77,000.

Post-IPO disclosed FY2025 results came in at revenue KRW 13.3bn, operating loss KRW 2.3bn, and net loss KRW 2.8bn—revenue slightly missed the IPO forecast of KRW 14.5bn, but losses were materially narrower than the projected operating loss of KRW 2.8bn and net loss of KRW 3.9bn.

Q1 2026 was a standout quarter, with revenue of KRW 6.57bn surging 123% year-over-year, demonstrating that growth momentum is materializing, while the operating loss narrowed to KRW 780mn as operating leverage began to feed through.

Q1 2026 order intake reached KRW 20.7bn, up 86% YoY, driven by new enterprise and telecom client additions and increased government AX project participation.

Twelve government AI national projects were secured during 2025 alone, building strategic references including the Ministry of Unification and the Ministry of Patriots and Veterans.

Shinhan Investment Securities projects FY2026 revenue of KRW 30.4bn (+128.6% YoY) and operating income of KRW 4.9bn, with a potential order opportunity exceeding KRW 100bn from NVIDIA's planned deployment of 260,000 GPUs in Korea. Current market capitalization of approximately KRW 200bn modestly exceeds the KRW 154.4bn IPO-price market cap.

Outlook

Acryl's official 2026 targets call for revenue of KRW 27.7bn, operating income of KRW 3.3bn, and net income of KRW 1.7bn, with Q1 2026 order intake of KRW 20.7bn serving as a meaningful leading indicator.

Revenue recognition from GPU-based AI infrastructure build-out projects is expected to accelerate in the second half of 2026, with orders linked to NVIDIA's domestic GPU deployment program targeted for Q3 2026.

For 2027, the company targets revenue of KRW 43.6bn, operating income of KRW 14.4bn, and net income of KRW 10.3bn, requiring Jonathan revenues to reach approximately KRW 23bn and NADIA to reach KRW 11.5bn.

The commercial progress of GPUBASE (GPU cluster optimization) and NADIA-ANE (AI-native EMR), including expansion into biotech, pharma and medical device clients, will be the decisive earnings leverage variables for 2026–2027.

The accelerating global trend toward sovereign AI—nations building independent AI infrastructure—is expanding a market segment that Acryl's public sector credentials and Jonathan's security and audit framework position it well to address.

Internationally, the company has established footholds in Central Asia (Uzbekistan, Karakalpakstan) and Southeast Asia (Malaysia, Indonesia), targeting Singapore and ultimately the U.S. market over the medium to long term.

The majority of IPO proceeds of KRW 42.1bn remaining undeployed provides a substantial runway for R&D and facility investment to underpin long-term growth.

Bull factors

Q1 Revenue Surge & Order Explosion

Q1 2026 revenue grew 123% YoY to KRW 6.57bn while the order backlog expanded to KRW 20.7bn (+86% YoY). Expansion of Jonathan's customer base and verticals, combined with growing government-led AX project participation, are simultaneously driving this growth.

If this momentum is sustained, the full-year breakeven target appears achievable, and above-trend order intake points to meaningful H2 earnings leverage.

The operating loss is also contracting materially year-over-year, demonstrating that fixed-cost dilution from revenue scale is beginning to feed through in reported numbers.

NVIDIA GPU Deployment Creates Large Deal Opportunity

Shinhan Investment Securities identified Acryl as a potential exclusive beneficiary of NVIDIA's plan to supply 260,000 GPUs in Korea, estimating the potential order opportunity at over KRW 100bn.

Acryl's GPUBASE solution—covering GPU monitoring, partitioning, virtualization, and optimization—is being positioned as a critical software layer for large-scale AI computing infrastructure.

The company is also expanding GPUBASE's validation coverage beyond NVIDIA GPUs to include domestic NPU and DPU environments, potentially establishing it as a key software partner within the Korean AI semiconductor ecosystem.

With Q3 2026 cited as the targeted visibility window, the timing aligns with the company's full-year breakeven goal, creating a potential call option on the upside.

Sovereign AI Tailwind & Public Sector Track Record

Acryl secured 12 government AI deployment and operation projects in 2025 alone, building strategic public sector references including the Ministry of Unification, Ministry of Patriots and Veterans, and Kyungpook National University Hospital.

The accelerating global sovereign AI trend—countries seeking independent AI infrastructure—elevates the competitive relevance of platforms with proven public sector credentials and robust security frameworks.

Jonathan's validated GPU operational automation capabilities and security-audit architecture create structural entry barriers in sensitive public and healthcare data environments.

Five consecutive years of AIIA 'Emerging AI+X Top 100' recognition and two consecutive years on Forbes Korea's 'AI 50' list further support customer acquisition and brand credibility.

Bear factors

Persistent Losses & Breakeven Execution Risk

Acryl carried a cumulative net loss of KRW 26.8bn as of end-2024 and posted a further net loss of KRW 2.8bn in FY2025.

While management has committed to operating breakeven in 2026, the lag between order intake and revenue recognition, combined with rising R&D and headcount costs, creates meaningful quarter-to-quarter P&L volatility.

Even with 123% Q1 revenue growth, the operating loss persists at KRW 780mn, meaning the full-year breakeven case is heavily back-half loaded and dependent on large project revenue recognition. A miss on targets would damage financial credibility and force a reassessment of the 2027 net income target of KRW 10.3bn.

Overhang Pressure & Thin Founder Ownership

CEO Park holds only 15.06% of shares, rising to just 22.64% including related parties—a relatively thin founder stake that raises concerns about control stability.

Lock-up expirations for multiple financial investors including LG Electronics (7.96%, second-largest shareholder) and Tigris Investment are arriving sequentially, creating a persistent overhang of potential profit-taking supply that could cap price recovery.

The historical existence as of end-2024 of KRW 15.5bn in redeemable convertible preferred shares and KRW 9.0bn in derivative liabilities (resolved in May 2025 via conversion) highlights the potential for balance sheet complexity.

As a micro-cap with a market cap of approximately KRW 200bn, the stock is structurally vulnerable to supply-side shocks.

Revenue Concentration & Intensifying Competition

Government subsidy revenue accounted for 27.1% of 2024 sales, creating exposure to policy shifts or budget cuts. Jonathan's high revenue concentration at 46.8% means delays in new product commercialization could slow the pace of revenue diversification.

The MLOps/LLMOps market faces intensifying competitive entry from both domestic AI startups and global hyperscaler platforms such as AWS SageMaker and Google Vertex AI, raising the risk of pricing pressure and customer acquisition challenges over time.

Hardware vendors like NVIDIA expanding their own software stacks (e.g., NEMO) could challenge Acryl's position as an independent AI infrastructure software layer.

Risk factors

Macro & Policy Risk

The pace of government AI infrastructure spending and direction of national AI strategy are directly linked to Acryl's public sector order pipeline. Policy priority shifts or budget cuts could reduce the AX project pipeline and impact the 27%-of-revenue government subsidy income stream.

A global macro slowdown or persistent high-rate environment could delay private sector AI infrastructure investment decisions, undermining the planned expansion into enterprise clients.

Tightening personal data protection and AI regulation could also slow AI platform adoption in healthcare and public sectors, creating headwinds for NADIA and Jonathan's public rollout.

Technology & Competitive Risk

The MLOps/LLMOps market faces potential commoditization as open-source ecosystems rapidly mature and global hyperscalers expand free cloud-based platform offerings, creating pricing pressure.

If proprietary LLM 'Areum' fails to maintain top-tier leaderboard performance, the technology differentiation narrative could weaken over time. Expanding GPUBASE to support domestic NPU and DPU hardware introduces technical complexity and certification risk that could delay commercialization timelines.

Hardware vendors like NVIDIA strengthening their own software stacks could structurally challenge Acryl's position as an independent AI infrastructure software layer.

Financial & Liquidity Risk

A cumulative net loss of KRW 26.8bn as of end-2024 means deferred tax benefits are not expected to activate until 2029, and if breakeven is delayed, the need for additional equity financing could emerge.

Additional capital raises would result in per-share dilution, and while the majority of IPO proceeds remain undeployed, they could be consumed in covering operating costs until profitability is achieved.

Sequential exits by financial investors will create ongoing overhang-driven supply pressure from a stock market perspective.

As a micro-cap with a market capitalization of approximately KRW 200bn, liquidity is limited and the stock is susceptible to elevated price volatility in response to macro events or shifts in investor sentiment toward AI themes.

Overall view

Acryl occupies a structurally attractive position at the intersection of sovereign AI and enterprise AI transformation infrastructure—themes with genuine secular tailwinds. Q1 2026's 123% revenue growth and 86% YoY order surge confirm that the growth thesis is translating into real numbers.

The company's public sector references, strategic ties with LG Electronics and SK C&C, proprietary LLM development, and GPUBASE GPU software positioning form a credible medium-term growth foundation.

However, accumulated losses through FY2025, the 2027-forward-earnings-based IPO valuation, and investor overhang continue to weigh on share price recovery.

The 2026 operating breakeven outcome will serve as the most critical re-rating catalyst—specifically, whether H2 2026 revenue recognition from NVIDIA GPU-linked and public AI infrastructure projects delivers on management's commitments.

A neutral stance is appropriate at this juncture, with risk-reward becoming more clearly definable after Q2–Q3 2026 result confirmation.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 12 more articles and sources

Report written 2026-06-05 · Data as of 2026-06-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.